शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
TORNTPHARMNSETorrent Pharmaceuticals Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 28 Jul, 2025 · 16:41 IST

Torrent Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.1%Reaction day
₹3630.00
prior close
₹3660.20
announcement price
After-mkt
timing
Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.6%+3.5% vs market
Pharmaceuticals peers, median of 149sector+0.8%+3.3% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty 100 and 3.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.0
10m
+1.1
15m
+1.0
30m
+1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.1+0.6+3.5+0.8+3.3
Next day
+2.8+0.8+2.0+0.9+1.9
2d
+3.4+0.4+3.1-0.1+3.5
3d
+0.8-0.5+1.4-2.1+2.9
4d
-0.7+0.2-0.9-1.4+0.7
5d
-1.2-0.1-1.1-2.0+0.8
1w
-1.0-0.4-0.6-3.3+2.4
15d
+1.0+1.6-0.6-3.2+4.2
1m
-1.8-1.1-0.7-5.3+3.5
2m
-1.0+0.1-1.1-5.9+4.9
3m
-0.7+5.5-6.2-5.2+4.6
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Torrent Pharmaceuticals has filed its quarterly financial results with NSE for the three months ended June 30, 2025. This is a standard regulatory disclosure following the close of Q1 FY26. The headline does not include any detailed financial figures, auditor commentary, or segment data. Retail investors should refer to the full results PDF for actual revenue, profit, margin, and cash flow numbers.

Likely market impact

This is a routine compliance filing — the actual impact on shareholders depends entirely on the numbers inside the results document, which are not reflected in the headline. Watch for revenue growth, profit trends, and any one-off charges when reviewing the full results.